2022 annual financial data
bioAffinity Technologies 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -84,756.3%.
Operating income was -4,011,058 USD and net income was -8,154,113 USD.
Operating cash flow was -4,070,845 USD.
Get free bioAffinity Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,803 USD
- Operating income
- -4,011,058 USD
- Net income
- -8,154,113 USD
- Operating cash flow
- -4,070,845 USD